Inventprise LLC
Pneumococcal conjugate vaccine (PCV-25) using novel vaccine platform technology
- Sector
- Biotech
- Headquarters
- REDMOND, WA
- Latest Form D
- $3.5M, Nov 2021
- Total capital
- $3.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.5M
- 1 Form D · last Nov 2021
- 59 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 23
- 14 pending · first 2017
- Rank in peer group#77 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$3.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#77 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Subhash KapreResearcherExecutive Officer, DirectorLinked by 17 patents
- David GoeslingExecutive OfficerNamed in SEC Form D filings
- Pradip GhateExecutive OfficerNamed in SEC Form D filings
- Yves LeurquinExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 23 granted of 37- GrantedDouble Chamber Device for Point of Use MixingUSPTOUS 12,383,682
- GrantedVLP Stabilized Vaccine CompositionsUSPTOUS 12,318,440
- GrantedImmunogenic Compositions of Polysaccharide-Protein Pegylated CompoundsUSPTOUS 12,251,438
Show all 37 patent records
- Double Chamber Device for Point of Use MixingAug 12, 2025 · US 12,383,682Granted
- VLP Stabilized Vaccine CompositionsJun 3, 2025 · US 12,318,440Granted
- Immunogenic Compositions of Polysaccharide-Protein Pegylated CompoundsMar 18, 2025 · US 12,251,438Granted
- Virus-Like Particle ConjugatesMar 4, 2025 · US 12,239,697Granted
- Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24FAug 6, 2024 · US 12,053,515Granted
- VLP Stabilized Vaccine CompositionsJan 23, 2024 · US 11,878,054Granted
- Just-In-Time Bioprocess Plant SystemNov 7, 2023 · US 11,809,172Granted
- Virus-Like Particle ConjugatesJul 19, 2022 · US 11,389,519Granted
- Mixtures Of Polysaccharide Protein Pegylated CompoundsJul 5, 2022 · US 11,376,323Granted
- Just-in-time Bioprocess Plant SystemJun 21, 2022 · US 11,366,458Granted
- Heat Stable VaccinesSep 7, 2021 · US 11,110,163Granted
- Multivalent Streptococcus VaccinesJul 22, 2021 · Application 17151445Pending
- Multivalent VLP ConjugatesApr 22, 2021 · Application 16987998Pending
- Double Chamber Device for Point of Use MixingApr 20, 2021 · US 10,981,129Granted
- VLP Stabilized Vaccine CompositionsSep 1, 2020 · US 10,758,606Granted
- Bordetella Pertussis Immunogenic Vaccine CompositionsAug 25, 2020 · US 10,751,404Granted
- Multivalent VLP ConjugatesAug 11, 2020 · US 10,736,952Granted
- Mixtures of Polysaccharide-Protein Pegylated CompoundsAug 4, 2020 · US 10,729,763Granted
- Polysaccharide Purification for Vaccine Production using Lytic Enzymes, Tangential Flow Filtration, and Multimode ChromatographyJul 7, 2020 · US 10,702,596Granted
- Multivalent Conjugate Vaccines With Bivalent Or Multivalent Conjugate Polysaccharides That Provide Improved Immunogenicity And AvidityJun 23, 2020 · US 10,688,170Granted
- Bacterial Growth on Non-Animal Derived MediaJun 11, 2020 · Application 16703511Pending
- Polysaccharide Purification for Vaccine Production using Lytic Enzymes, Tangential Flow Filtration, and Multimode ChromatographyOct 8, 2019 · US 10,435,433Granted
- Heat Stable Liquid Rotavirus VaccineSep 17, 2019 · US 10,413,604Granted
- Multivalent VLP ConjugatesDec 25, 2018 · US 10,159,728Granted
- Bordetella Pertussis Immunogenic Vaccine CompositionsSep 18, 2018 · US 10,076,563Granted
- Genetically Detoxified Pertussis Vaccine that Maintains Intrinsic Adjuvant ActivityNov 21, 2017 · US 9,821,056Granted
- Bordetella Pertussis Immunogenic Vaccine CompositionsApplication PCTUS2016028093Pending
- Multivalent Streptococcus VaccinesApplication PCTUS2021013818Pending
- Bacterial Growth On Non-animal Derived MediaApplication PCTUS2019064495Pending
- Just-in-time Bioprocess Plant SystemApplication PCTUS2019061918Pending
- Virus-like Particle ConjugatesApplication PCTUS2019036243Pending
- Double Chamber Device For Point Of Use MixingApplication PCTUS2018043379Pending
- Polysaccharide Purification For Vaccine Production Using Lytic Enzymes, Tangential Flow Filtration, And Multimode ChromatographyApplication PCTUS2018040296Pending
- Multivalent Conjugate Vaccines With Bivalent Or Multivalent Conjugate Polysaccharides That Provide Improved Immunogenicity And AvidityApplication PCTUS2018036868Pending
- Heat Stable Liquid Rotavirus VaccineApplication PCTUS2018018226Pending
- Multivalent Vlp ConjugatesApplication PCTUS2016051264Pending
- Vlp Stabilized Vaccine CompositionsApplication PCTUS2016050375Pending
Related companies, and why
- Virax Biolabs Group LtdSimilar federal contract value in Biotech · null in contracts
- MingSight Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Attivare Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- YAP Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- La Jolla Labs IncSimilar federal contract value in Biotech · null in contracts
- Cairn Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .